REVOLUTIONARY DIAGNOSTICS

With no instruments, laboratories and medical staff

Our vision is to make reliable diagnostics accessible to everyone, anywhere, anytime.

We have been developing a diagnostic solution that removes traditional barriers of time, cost, and infrastructure, helping close the global gap in access to healthcare. Lab On Card is a microfluidic point-of-care platform designed to deliver rapid laboratory-grade immunoassays outside centralized labs.

wired-outline-438-lab-bottle-round-hover-oscillate (2)

Laboratory-Grade Performance

Miniaturizing the gold-standard ELISA method into a pocket-sized format while preserving laboratory-grade performance, delivering rapid results from a single drop of blood.

wired-outline-955-demand-hover-click (1)

Diagnostics Without Barriers

Addressing the diagnostic needs of the 4.5 billion people worldwide who currently lack access to essential healthcare services.

wired-outline-950-attract-customers-hover-pinch (1)

Built to scale

A scalable diagnostic platform addressing a $240BN market, built on the synergy of clinical R&D and advanced nanostructuring.

Social Impact

The flexible diagnostic platform supports earlier clinical decisions.

Our research and development combines biochemical assay design and microfluidic engineering, with in-house scale-up manufacturing as a core part of the development process.

wired-outline-19-magnifier-zoom-search-hover-spin (1)

Discovery

Biomarker selection and microfluidic architecture design.

wired-outline-981-consultation-hover-conversation (1)

Proof of Concept

Demonstration of laboratory-grade assay performance on real biological samples.

wired-outline-1325-code-fork-hover-pinch (1)

Assay Development

Validation of assay specificity, sensitivity, LOD and shelf-life stability.

Production Feasibility

Selection of technologies suitable for in-house scale-up.

wired-outline-966-privacy-policy-hover-swipe (1)

Certification

Preparation for regulatory approval process.

wired-outline-955-demand-hover-click (2)

Business

Strategic partnerships, licensing, and scalable manufacturing for global deployment.

ASSAY DEVELOPMENT

Assay development prioritizes high-impact infectious diseases and later supports the expansion of the platform to other clinical indications.

The company was founded through the collaboration of experts with extensive experience in clinical diagnostics and micro- and nanostructuring.

Michal Pohludka

Martin Radina

Martin Jotov

Tomáš Těthal

Petr Franc

The management team brings together expertise across biochemistry, immunoassay and ELISA development, microfluidics, materials science, and nano- and micro-structuring.